Jui-Hung Tsai

Jui-Hung Tsai

Auto-generated profile, based on publicly available information

Jui-Hung Tsai

Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2023 in Materials Today Bio
Verified
Journal Article
Open access
TNThi Kim Ngan Ngo
Thi Kim Ngan Ngo
SYSze Jue Yang
Sze Jue Yang
BMBin-Hsu Mao
Bin-Hsu Mao
TNThi Kim Mai Nguyen
Thi Kim Mai Nguyen
QNQi Ding Ng
Qi Ding Ng
Ting-Yuan TUTing-Yuan TU
Ting-Yuan TU
Metastasis is the leading cause of cancer-related deaths. During this process, cancer cells are likely to navigate discrete tissue-tissue interfaces, enabling them to infiltrate and spread throughout the body. Three-dimensional (3D) spheroid modeling is receiving more attention due to its strengths in studying the invasive behavior of metastatic cancer cells. While microscopy is a conventional approach for investigating 3D invasion, post-invasion image analysis, which is a time-consuming process, remains a significant challenge for researchers. In this study, we presented an image processing pipeline that utilized a deep learning (DL) solution, with an encoder-decoder architecture, to assess and characterize the invasion dynamics of tumor spheroids. The developed models, equipped with feature extraction and measurement capabilities, could be successfully utilized for the automated segmentation of the invasive protrusions as well as the core region of spheroids situated within interfacial microenvironments with distinct mechanochemical factors. Our findings suggest that a combination of the spheroid culture and DL-based image analysis enable identification of time-lapse migratory patterns for tumor spheroids above matrix-substrate interfaces, thus paving the foundation for delineating the mechanism of local invasion during cancer metastasis.

27 September 2024 in Palliative Medicine
Verified
Journal Article
Open access
HLHui-Ju Liang
Hui-Ju Liang
QXQian Xiong
Qian Xiong
PLPeng-Chan Lin
Peng-Chan Lin
JTJui-Hung Tsai
Jui-Hung Tsai
NPNancy Preston
Nancy Preston
Background: Adequate death preparation positively influences families’ experience before death and during bereavement. However, how to prepare families in non-Western cultures has received scant attention. Aim: To explore family caregivers’ experiences in preparing for a relative’s death in specialist palliative care in Taiwan. Design: A qualitative study employing reflexive thematic analysis of data collected from semi-structured interviews was conducted. Setting/participants: Twenty-two family caregivers from seven hospitals participated. Results: The overarching theme was ‘getting everything right to have no regrets between the dead and the living’. We developed two themes to explain preparations for the time surrounding and after the death, including the deceased’ afterlife: (1) ‘having a good ending but not the end of the relationship’, which addresses preparations for the death itself, the funeral, the afterlife and maintaining connections and (2) ‘using religious beliefs and cultural norms to guide preparation’, which explores perceptions of a good death, including refrain from strong emotions before and after the death. Conclusion: Funeral arrangements, enhancing the deceased’s afterlife and maintaining connections to the deceased are crucial for families’ experiences which can be impacted by actions they take as they prepare for the death. A culturally appropriate death is beneficial for the dying relative which includes preparing to not show strong emotions during and after the death. These insights inform the importance of the cultural context in death preparation in Taiwan and provide perspectives for palliative care beyond Western culture, potentially benefiting Chinese populations, predominantly East Asian and Buddhist societies.

10 February 2025 in Palliative Medicine
Verified
Journal Article
Open access
HLHui-Ju Liang
Hui-Ju Liang
QXQian Xiong
Qian Xiong
PLPeng-Chan Lin
Peng-Chan Lin
JTJui-Hung Tsai
Jui-Hung Tsai
NPNancy Preston
Nancy Preston
Background: Death preparations can benefit families both before and during bereavement. While these preparations are culturally influenced, evidence from non-Western cultures, like Eastern Asia, is limited. Aim: To explore how family caregivers prepare for a relative’s death in Taiwan. Design: A qualitative interview study analysed with reflexive thematic analysis. Setting/participants: Twenty-two primary family caregivers following a death involving specialist palliative care were interviewed. Results: An overarching theme was ‘getting everything right to have no regrets between the dead and the living’. Within this, two themes focussed upon improving the dying relative’s outcomes and the families’ subsequent bereavement: (1) ‘making the right end-of-life decisions is crucial but complex’, exploring preparations to involve (or not) the dying relative in making choices to minimise regrets. Participants often felt they understood the dying relative’s wishes so respected their preferences while maintaining family harmony through consensus-building and professional guidance. (2) ‘becoming a competent caregiver is the priority’, addressing preparations for fulfilling responsibilities, making sacrifices and developing caregiving competence to ensure the dying relative’s comfort. This would help reduce feelings of regret about not having done enough. Conclusion: Preparing for end-of-life decisions and caregiving is important for participants to reduce regret, benefiting subsequent bereavement. Of particular importance is family involvement and consensus-building in end-of-life decisions, reflecting Taiwan’s family-led culture. These findings can inform clinical practices in family-centric decision-making cultures where healthcare workers should be aware of the need to build consensus, sometimes without involving the dying person. Future research should include patients’ and healthcare professionals’ perspectives.

3 January 2025 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
HOHuang-Tz Ou
Huang-Tz Ou
JTJui-Hung Tsai
Jui-Hung Tsai
YCYi-Lin Chen
Yi-Lin Chen
TWTzu-I. Wu
Tzu-I. Wu
LCLi Jun Chen
Li Jun Chen
SYSzu-Chun Yang
Szu-Chun Yang

17 December 2025 in PharmacoEconomics
Verified
Journal Article
Open access
PDF file
HOHuang-Tz Ou
Huang-Tz Ou
JTJui-Hung Tsai
Jui-Hung Tsai
YCYi-Lin Chen
Yi-Lin Chen
TWTzu-I. Wu
Tzu-I. Wu
LCLi Jun Chen
Li Jun Chen
SYSzu-Chun Yang
Szu-Chun Yang

28 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
JTJui-Hung Tsai
Jui-Hung Tsai
ILI-Ting Liu
I-Ting Liu
PSPei-Fang Su
Pei-Fang Su
YHYing-Tzu Huang
Ying-Tzu Huang
GCGe-Lin Chiu
Ge-Lin Chiu
PLPeng-Chan Lin
Peng-Chan Lin
PurposeLimited efficacy has been observed when using morphine to treat neuropathic pain. Lidocaine patches reduce neuropathic pain in post-herpetic neuralgia, but their benefits for cancer-related neuropathic pain remain unclear. This study aimed to demonstrate a useful treatment for cancer-related neuropathic pain. The primary endpoint was pain intensity evaluated by the visual analog scale (VAS). The secondary endpoints were the pain relief score and the quality of analgesic treatment. MethodsWe assessed the efficacy and safety of lidocaine patches in patients experiencing neuropathic cancer pain. Terminal cancer patients with opioid treatment resistance participated in the 3-day study. ResultsThe results showed a statistically significant difference in the median VAS over three days (Kruskal-Wallis test, P<0.0001). The median VAS pain intensity from Day 1 to Day 3 was 4.0 with 95% C.I. (3.3, 5.0), 3.0 (2.5, 3.5) and 2.5 (2.0, 3.0), respectively. The difference between the median VAS pain intensities of any two days was statistically significant (Wilcoxon signed-rank test, P < 0.0001). There was no statistically significant difference in the pain relief score or the quality of analgesic treatment. ConclusionIn this study, the 5% lidocaine transdermal patch reduced the VAS pain intensity in neuropathic cancer patients with morphine resistance. The transdermal patch is generally useful and well-tolerated.